Development of Engineered Trypsin for Proteomics Sample Prep.

Information

  • Research Project
  • 9846124
  • ApplicationId
    9846124
  • Core Project Number
    R43GM134752
  • Full Project Number
    1R43GM134752-01
  • Serial Number
    134752
  • FOA Number
    PA-18-574
  • Sub Project Id
  • Project Start Date
    9/1/2019 - 5 years ago
  • Project End Date
    8/31/2020 - 4 years ago
  • Program Officer Name
    KREPKIY, DMITRIY
  • Budget Start Date
    9/1/2019 - 5 years ago
  • Budget End Date
    8/31/2020 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/12/2019 - 5 years ago
Organizations

Development of Engineered Trypsin for Proteomics Sample Prep.

ABSTRACT Significance: Next generation sequencing (NGS) has has transformed the field of genomics and enabled broad adoption of the technology in biological, translational, and most recently clinical research. The proteomics equivalent to NGS has not yet been realized. As such, more accessible and cost-effective technologies for analysis of the proteome would accelerate biological and medical research. The goal of this proposal is to develop a highly-scalable digital protein analysis technology. The approach is broadly applicable and greatly improves upon cost, sensitivity, usability, and throughput of current approaches. Approach: We are developing a single molecule digital peptide sequencing platform using highly-parallelized single molecule Edman degradation and DNA encoding. Our assay generates a DNA library representing peptide sequence information on millions to billions of peptides that is sequenced on a standard NGS instrument. In this proposal, we are focused on developing reagents to expedite DNA tagging of the millions to billions of peptides for our assay by engineering proteases to cleave at modified sites. Impact: In summary, we believe our Next-Gen peptide sequencing assay will usher in the era of ?next gen proteomics? effectively transforming biological, translational, and clinical research, much like NGS technology has already done in the genomics space.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    224579
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:224579\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ENCODIA, INC.
  • Organization Department
  • Organization DUNS
    079752755
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921211213
  • Organization District
    UNITED STATES